Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
Pruschy Martin | KLS 02788-02-2011 | CHF 317 400.–<br />
Labor für molekulare Radiobiologie, Klinik für Radio-Onkologie, UniversitätsSpital Zürich, Zürich<br />
Targeting of ionizing radiation-activated treatment resistances: radiation-induced para- and autocrine factors<br />
Roosnek Eddy | KFS 02830-08-2011 | CHF 249 900.–<br />
Service d’hématologie, Hôpitaux universitaires de Genève (HUG), Genève<br />
Novel methods to quantify inflammatory disease and immunity to adjust therapeutical interventions in patients<br />
after haematopoietic stem cell transplantation<br />
Ruiz Christian | KFS 02780-02-2011 | CHF 196 500.–<br />
Institut für Pathologie, Universitätsspital Basel, Basel<br />
Comprehensive analysis of the genomic evolution of clonal populations in the progression of hormone-sensitive<br />
prostate and breast cancers<br />
Schanz Urs | KFS 02858-08-2011 | CHF 169 900.–<br />
Klinik für Hämatologie, UniversitätsSpital Zürich, Zürich<br />
EBMT HCT vs CT in elderly AML: a randomized phase III study comparing conventional chemotherapy<br />
to low dose total body irradiation-based conditioning and haematopoietic cell transplantation from related<br />
and unrelated donors as consolidation therapy for older patients with AML in first complete remission<br />
Schwenkglenks Matthias | KLS 02757-02-2011 | CHF 217 400.–<br />
Institut für pharmazeutische Medizin, Universität Basel, Basel<br />
A health economic cost-utility analysis alongside the randomized controlled clinical trial SAKK 75 / 08:<br />
multimodal therapy with and without cetuximab in patients with locally advanced oesophageal carcinoma:<br />
an open-label phase III trial<br />
Speiser Daniel E. | KFS 02836-08-2011 | CHF 343 700.–<br />
Clinical Tumor Biology & Immunotherapy Unit, Centre Ludwig de l’Université de Lausanne pour la recherche<br />
sur le cancer, Hôpital Orthopédique / CHUV, Lausanne<br />
Characterization of T-cell activation and suppression in melanoma patients by ex vivo analysis of myeloid,<br />
lymphoid and tumour cells<br />
Terracciano Luigi M. | KFS 02867-08-2011 | CHF 196 500.–<br />
Institut für Pathologie, Universitätsspital Basel, Basel<br />
Dissecting the role of HOXA13 in hepatocarcinogenesis<br />
Vassella Erik | KFS 02826-08-2011 | CHF 204 400.–<br />
Institut für Pathologie, Universität Bern, Bern<br />
Role of microRNAs in regulating EGFR signalling and cytotoxicity induced by receptor tyrosine kinase inhibitors<br />
in non-small cell lung cancer<br />
Zucca Emanuele | KFS 02859-08-2011 | CHF 320 000.–<br />
Istituto oncologico della Svizzera italiana (IOSI), Ospedale San Giovanni, Bellinzona<br />
A randomized, open-label, multicentre, two-arm phase III comparative study assessing the role of mediastinal<br />
radiotherapy after rituximab-containing chemotherapy to patients with newly diagnosed primary mediastinal<br />
large B-cell lymphoma (PMLBCL)<br />
Bewilligte Stipendien 2011<br />
Totalbetrag der bewilligten Mittel: CHF 263 400.–<br />
Kim Corina | BIL KFS 02806-08-2011 | CHF 67 000.–<br />
Sympathetic nervous system regulation of pancreatic cancer progression<br />
Zielort: Peter MacCallum Cancer Center, Monash University, Melbourne, Australia<br />
Negretti Laura | BIL KFS 02807-08-2011 | CHF 13 900.–<br />
Postgraduierter Lehrgang in Sexualmedizin und Sexualtherapie<br />
Zielort: Abteilung gynäkologische Sozialmedizin und Psychosomatik, Frauenklinik, Universitätsspital Basel, Basel<br />
Soldini Davide | BIL KLS 02790-02-2011 | CHF 54 500.–<br />
Study of the role of cell competition in human neoplastic diseases<br />
Zielort: Hammersmith Hospital, Imperial College, London, United Kingdom<br />
Templeton Arnoud | BIL KFS 02805-08-2011 | CHF 128 000.–<br />
Clinical and research fellowship genitourinary oncology<br />
Zielort: Princess Margaret Hospital and University of Toronto, Toronto, Canada<br />
105
Change language